Previously, upregulation of COL6A3 has been reported in platinum-resistant OC cells in vitro, and inhibition of the cleaved product of COL6A3, endotrophin, can sensitize cisplatin-resistant breast cancer cells45,46. Here, COL6A3 is linked to breast carcinoma.